A resolution designating July 19, 2023, as "Glioblastoma Awareness Day".
SRES 257 is a symbolic Senate resolution designating July 19, 2023, as "Glioblastoma Awareness Day." It does not create new laws or funding but formally recognizes the severity of glioblastoma - a rare, aggressive brain cancer with a 6.9% 5-year survival rate - through a designated awareness day. The resolution encourages public awareness, honors those affected by the disease, and supports ongoing research efforts like the Glioblastoma Therapeutics Network. It has no direct impact on patients or healthcare policy, serving only as a ceremonial acknowledgment.
Bill status
passed
3 of 5 stages cleared
Introduction
Jun 2023
Committee Review
Senate Passage
Jun 2023
House Passage
President
Introduced Jun 15, 2023
Last action Jun 15, 2023
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
0
Amendments
1
Jun 15, 2023
Introduced
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2127-2128; text: CR S2127)
upper
Jun 15, 2023
Upper · Passed
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2127-2128; text: CR S2127)
upper
Jun 15, 2023
Introduced
Introduced in Senate
upper
1 primary · 8 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SRES 257
Scope: US
Hi! I can help you understand SRES 257. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline